Cathay Biotech Inc. (SHA:688065)
54.68
+0.30 (0.55%)
Feb 27, 2026, 3:00 PM CST
Cathay Biotech Revenue
Cathay Biotech had revenue of 874.27M CNY in the quarter ending September 30, 2025, with 13.43% growth. This brings the company's revenue in the last twelve months to 3.29B, up 18.96% year-over-year. In the year 2024, Cathay Biotech had annual revenue of 2.96B with 39.91% growth.
Revenue (ttm)
3.29B
Revenue Growth
+18.96%
P/S Ratio
11.99
Revenue / Employee
1.90M
Employees
1,764
Market Cap
39.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.96B | 843.74M | 39.91% |
| Dec 31, 2023 | 2.11B | -326.93M | -13.39% |
| Dec 31, 2022 | 2.44B | 77.62M | 3.28% |
| Dec 31, 2021 | 2.36B | 866.29M | 57.86% |
| Dec 31, 2020 | 1.50B | -419.01M | -21.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xinfengming Group | 69.44B |
| Hubei Xingfa Chemicals Group | 30.13B |
| Haohua Chemical Science & Technology Corp. | 16.06B |
| Inner Mongolia Berun Chemical Company | 11.55B |
| Do-Fluoride New Materials | 8.02B |
| Zhejiang Sanmei Chemical Industry | 5.43B |
| Sichuan Em Technology | 5.03B |
| Chengxin Lithium Group | 4.18B |